SCHEMBL4787372

SCHEMBL4787372

C=CCC1(CC=C)c2[c]cccc2-c2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PGR P06401 2/20 0.40
APEX1 P27695 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL88451 0.80 PGR (0.49) PGRAPEX1
SCHEMBL30511096 0.80 PGR (0.49) PGRAPEX1
SCHEMBL379780 0.78 PGR (0.36) PGRAPEX1
SCHEMBL10010105 0.75 PGR (0.39) PGRAPEX1
SCHEMBL1723731 0.74 PGR (0.40) PGRAPEX1
SCHEMBL10009392 0.73 APEX1 (0.36) PGRAPEX1
Alcohol SCHEMBL28871387 0.73 PGR (0.43) PGRAPEX1
SCHEMBL2942957 0.72 PGR (0.41) PGRAPEX1
SCHEMBL19949686 0.71 KDM4E (0.41)
SCHEMBL21858109 0.71 KDM4E (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008117633-A1 COMPOSITION, METHOD FOR FABRICATING LIGHT-EMITTING ELEMENT, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-10-02 WO disclosed
US-20080233432-A1 an organometallic complex is dissolved and a method for fabricating a light-emitting element using the composition, and to provide a light-emitting element, a light-emitting device, and an electronic device each fabricated using the composition in which the organometallic complex is dissolved. SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2008-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080233432-A1 an organometallic complex is dissolved and a method for fabricating a light-emitting element using the composition, and to provide a light-emitting element, a light-emitting device, and an electronic device each fabricated using the composition in which the organometallic complex is dissolved. LAGE3, PPOX, NOX5 PGR 2202/4885APEX1 1163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.